Save The Date: Roche Virtual Event – Key ophthalmology data presented at the Angiogenesis 2023 Meeting

  We are pleased to invite investors and analysts to participate in our virtual event onMonday, 13February 2023, highlighting Roche data presented at the virtual Angiogenesis, Exudation, and Degeneration 2023 Meeting, from 10th to 11th February. 16:30 – 18:00 CET / 15:30– 17:00 GMT10:30 – 12:00pm EST / 7:30 –9:00 am PST An invitation with the detailed programme and registration link will follow soon.  Best regards, Bruno EschliHead of Investor Relations  Loren KalmHead of Investor Relations, North AmericaRoche Investor Relations Dr. BrunoEschliPhone: [phone]e-mail:[e-mail] Dr. SabineBorngr äberPhone: [phone]e-mail:[e-mail] Dr. BirgitMasjostPhone: [phone]e-mail:[e-mail] Dr. Gerard TobinPhone: [phone]e-mail:[e-mail]  Investor Relations North America Loren KalmPhone: [phone]e-mail:[e-mail] 

Source: Roche Investor Update - January 13, 2023 Category: Pharmaceuticals Source Type: news